ECEunjeong Choi

Eunjeong Choi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eunjeong Choi has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Doosoo Jeon

    Department of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Republic of Korea

    1 shared publication
  • Hye Ju Yeo

    Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea

    1 shared publication
  • Jin Ho Jang

    From the Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Pusan National University School of Medicine, Transplantation Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea

    1 shared publication
  • Taehwa Kim

    Division of Pulmonology, Critical Care Medicine, Department of Internal Medicine, Kosin University Gospel Hospital, Busan, Korea

    1 shared publication
  • Woo Hyun Cho

    Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea

    1 shared publication
  • Yun Seong Kim

    From the Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Pusan National University School of Medicine, Transplantation Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea

    1 shared publication

Latest Publications

  • Open Access

    Navigating the Modern Landscape of Sepsis: Advances in Diagnosis and Treatment

    by Jin Ho Jang, Eunjeong Choi, Taehwa Kim, Hye Ju Yeo, Doosoo Jeon, Yun Seong Kim, Woo Hyun Cho

    Sepsis poses a significant threat to human health due to its high morbidity and mortality rates worldwide. Traditional diagnostic methods for identifying sepsis or its causative organisms are time-consuming and contribute to a high mortality rate. Biomarkers have been developed to overcome these limitations and are currently used for sepsis diagnosis, prognosis prediction, and treatment response assessment. Over the past few decades, more than 250 biomarkers have been identified, a few of which have been used in clinical decision-making. Consistent with the limitations of diagnosing sepsis, there is currently no specific treatment for sepsis. Currently, the general treatment for sepsis is conservative and includes timely antibiotic use and hemodynamic support. When planning sepsis-specific treatment, it is important to select the most suitable patient, considering the heterogeneous nature of sepsis. This comprehensive review summarizes current and evolving biomarkers and therapeutic approaches for sepsis.